EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

De novo direct sequencing of small therapeutic RNAs by layer-by-layer intensity-resolved mass spectrometry

Shangsi Lin iD, Sophia Jiang, Lin Tang, Sateesh Kumar Kumbhakonam, Justin C Dingman, Jung Yeon Lee, Ruixin Yang, Tony Frudakis, Michele Kirchner, Sihang Xu, Chuanjuan Tao, Xuanting Wang und 4 weitere

Nucleic Acids Research · 22.06.2026 · 54 (12)

DOI: 10.1093/nar/gkag654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 02.07.2026. Verfasst von Shangsi Lin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and The RNA Institute, University at Albany, State University of New York, Albany, NY 12222, United States. Hauptthemen laut MEDLINE: Sequence Analysis, RNA, High-Throughput Nucleotide Sequencing, RNA, Small Interfering, Mass Spectrometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHGRI NIH HHS, NICHD NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid growth of RNA-based therapeutics demands accurate sequencing of all RNA species, including minor and modified variants. Conventional LC-MS/MS typically confirms only a predefined target sequence rather than determining RNA sequences de novo from the analyzed sample, thereby overlooking coexisting impurities and modifications. Here, we present 3D NGMS-Seq, a three-dimensional next-generation mass spectrometry-based sequencing platform for de novo direct sequencing of mixed RNA samples with essentially 100% sequence accuracy. This method incorporates MS intensity into traditional 2D mass–retention time (tR) analysis and introduces a nested algorithm that aligns ladder fragment intensities with parent RNA abundances for computational separation. Controlled acid hydrolysis produces RNA ladder fragments, which are segregated into mass-intensity-tR layers. Within each layer, short reads are generated de novo by sequentially base-calling each nucleotide, canonical or modified, from mass differences between adjacent ladder fragments and subsequently assembled into full-length RNA sequences. Guided by hydrolysis kinetics and statistical modeling, 3D NGMS-Seq accurately sequences synthetic siRNA, miRNA, and CRISPR/Cas9 sgRNAs, reveals unexpected low-abundance RNA impurities, and resolves subtle methylation ambiguities (Um versus mU; Am versus mA), while providing a quantitative profile of each RNA’s relative abundance and site-specific modifications. By enabling direct, unbiased sequencing of heterogeneous RNAs without prior sequence knowledge, 3D NGMS-Seq addresses key limitations of current RNA analysis and provides a powerful tool to aid small RNA drug development, quality control, and regulatory validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sequence Analysis, RNAHigh-Throughput Nucleotide SequencingRNA, Small InterferingMass SpectrometryMicroRNAsAlgorithmsHumansRNA, Guide, CRISPR-Cas Systems

Substanzen

RNA, Small InterferingMicroRNAsRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Department of Chemistry and The RNA Institute, University at Albany, State University of New York, Albany, NY 12222, United States.
  • Department of Biological and Chemical Sciences, New York Institute of Technology, New York, NY 10023, United States.
  • DirectSeq Biosciences, Inc., Albany, NY 12222, United States.
  • Center for Genome Technology and Biomolecular Engineering, Department of Chemical Engineering, Columbia University, New York, NY 10027, United States.
  • Molecular Medicine Program, Department of Human Genetics, and Division of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT 84132, United States.

ORCID-Profile: Shangsi Lin, Shenglong Zhang

Förderung

  • NHGRI NIH HHS
  • NICHD NIH HHS
  • NIEHS NIH HHS
  • US National Institutes of Health

Zitieren

APA

Lin, S., Jiang, S., Tang, L., Kumbhakonam, S. K., Dingman, J. C., Lee, J. Y., Yang, R., Frudakis, T., Kirchner, M., Xu, S., Tao, C., Wang, X., Russo, J. J., Zhang, X., Chen, Q., & Zhang, S. (2026). De novo direct sequencing of small therapeutic RNAs by layer-by-layer intensity-resolved mass spectrometry. Nucleic Acids Research, 54(12). https://doi.org/10.1093/nar/gkag654

Vancouver

Lin S, Jiang S, Tang L, Kumbhakonam SK, Dingman JC, Lee JY, et al. De novo direct sequencing of small therapeutic RNAs by layer-by-layer intensity-resolved mass spectrometry. Nucleic Acids Research. 2026;54(12). doi:10.1093/nar/gkag654

BibTeX
@article{Lin2026,
  author = {Lin, Shangsi and Jiang, Sophia and Tang, Lin and Kumbhakonam, Sateesh Kumar and Dingman, Justin C and Lee, Jung Yeon and Yang, Ruixin and Frudakis, Tony and Kirchner, Michele and Xu, Sihang and Tao, Chuanjuan and Wang, Xuanting and Russo, James J and Zhang, Xudong and Chen, Qi and Zhang, Shenglong},
  title = {De novo direct sequencing of small therapeutic RNAs by layer-by-layer intensity-resolved mass spectrometry},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {12},
  doi = {10.1093/nar/gkag654}
}
Kostenlos starten →